4//SEC Filing
Dispersyn Gerrit 4
Accession 0001209191-22-010384
CIK 0001533040other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 8:03 PM ET
Size
5.0 KB
Accession
0001209191-22-010384
Insider Transaction Report
Form 4
Dispersyn Gerrit
Chief Development Officer
Transactions
- Award
Common stock, $0.0001 par value
2022-02-15+126,000→ 221,281 total
Footnotes (2)
- [F1]Represents shares underlying a restricted stock unit, which shares will vest in three equal annual installments.
- [F2]Includes shares of common stock underlying unvested restricted stock units.
Documents
Issuer
Phio Pharmaceuticals Corp.
CIK 0001533040
Entity typeother
Related Parties
1- filerCIK 0001704417
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 8:03 PM ET
- Size
- 5.0 KB